Table 2.
Comparison of technical performance of the reviewed EIS-based sensors for diagnosis of COVID-19.
Electrode Type | Working Electrode | Sample Volume | Response Time | Analyte | Capture Element | Linear Range | Detection Limit | Real Sample | Reference |
---|---|---|---|---|---|---|---|---|---|
Fully integrated | Carbon + AuNP | 5 L | – | RBD protein | Aptamer | 1 × 10–25 × 10 M (5.08 × 10–1.27 × 10 g/mL) | 1.30 × 10 M (66 pg/mL) | – | [48] |
Fully Integrated | Au + rGO flakes | 30 L | 15 s | S1 protein Ab RBD protein Ab | S1 protein RBD protein | S1: 1 × 10– 30 × 10 M RBD: 1 × 10–20 × 10 M | S1: 2.8 × 10 M RBD: 16.9 × 10 M | – | [49] |
Fully Integrated | Au | 15 L | 45 min | SARS-CoV-2 pseudo types VSV particle | S1 protein Ab | 10–10 VSV/mL | 15 ng/mL (500 pM) | – | [50] |
Fully Integrated | Carbon Ink + AuNP | 10 L | 30 min | S protein Ab | S1 protein | 10 × 10 to 10 × 10 | 3.16 pM (83.7 pg/mL) | – | [9] |
Fully Integrated | Carbon Ink | 0.3 L | 5 min | S protein | S protein mAb | 1–20 fg/mL | 1.065 fg/mL | – | [59] |
Fully Integrated | Carbon + Graphene + PEDOT:PSS | 50 L | 30 min | N protein | N protein Ab | 1–10,000 pg/mL | 116 fg/mL | Nasopharyngeal swab | [71] |
Fully Integrated | Carbon Ink | 4 L | 2 min | S protein | ACE2 | 10 fg/mL–100 ng/mL | 2.18 fg/mL | Saliva, Oropharyngeal and Nasopharyngeal swabs | [70] |
Fully Integrated (Dropsens) | Au | 50 L | 15 min | RBD protein S protein Lysed COVID-19 particles | Targeting peptide | 102–103 copies/mL | 0.01 copies/mL | Nasopharyngeal swabs | [61] |
Fully Integrated (Dropsens) | Au | 10 L | 45 min | S protein | ACE2 receptor CD147 receptor | ACE2: 700–7000 ng/mL CD147: 500 ng–5000 ng/mL | ACE2: 299.30 ng/mL CD147: 38.99 ng/mL | Oropharyngeal and Nasopharyngeal swabs | [62] |
Fully Integrated (Dropsens) | Au | 50 L | 2 min | SARS-CoV-2 | Molecularly-imprinted polymer | 3.0–7.0 log10 PFU/mL | 4.9 log10 pfu/mL | Saliva | [53] |
Fully Integrated (Gamry) | Carbon + CNT + Tungsten Trioxide | 5 L in 2.95 mL PBS | 3 min | Whole Virus - Human-obtained sample, grown in cell line | Virus-imprinted monomer (3-aminophenol) | Up to 320 pg/mL tested | 57 pg/mL | Nasopharyngeal swabs | [54] |
Fully integrated (Paper, wax printed) | Carbon Graphene ink | 10 L | 5 min | RBD Protein | S1 IgG Ab | 0.25 fg/mL–1 ng/mL | 0.25 fg/mL | Nasopharyngeal swabs | [52] |
Fully Integrated (Paper) | Carbon + Zinc-Oxide Nanowires | 3 L | 15 min | S1 protein Ab | N protein | Tested: 10 × 10–1 × 10 g/mL | 0.4 pg/mL | Serum | [56] |
Interdigitated | Au + Carboxylmethylchitosan | Immersion | 10 min | S protein Real samples | anti-S protein Ab | Protein: × 10– × 10 g/mL Real Sample: 7 × 10–7 × 10 PFU/mL | 0.179 fg/mL | Isolated real virus | [66] |
Interdigitated | PEDOT:PSS | Aerosol | 5 min | S protein | Antibody | – | 7 pfu/mL, 350 pfu/mL (air) | Aerosolized porcine transmissible gastroenteritis virus | [69] |
Interdigitated | Au + diamond nanopowder | 20 L | 5 min | N protein | N protein aptamer | 1 × 10–1 × 10 M | 0.389 fM | – | [67] |
Single Electrode | Tin-doped indium oxide + polypyrrole + AuNP | 2 L | 15 min | SARS-CoV-2 Nucleocapsid Gene | Amino-modified primer | 800–4000 copies/L | 258.01 copies/L | Nasopharyngeal | [51] |
Working Only | Carbon (Pyrolyzed Graphitic Paper) | 6 L | 30 min | COVID-19 Ab | S protein | – | – | – | [58] |
Working Only | Carbon + AuNP | 10 L | 40 min | N protein | N protein murine Ab | 0.1–100 ng/mL | 6 pg/mL | Saliva | [64] |
Working Only | Glassy Carbon + rGO | 10 L | – | RBD protein | S1 protein Ab | 0.16–40 g/mL | 150 ng/mL | Saliva | [65] |
Working Only | Graphene powder in ethyl cellulose (custom ink) | 15 L | 30 min | RBD protein S1 protein | S protein (Rabbit PAb) | 1–1000 ng/mL | 22.91 ± 4.72 pg/mL (RBD) 110.38 ± 9.00 pg/mL (S1) | – | [60] |
Working Only | Thin-Film Au Electrode | – | 15 min | S1 protein | Aptamer | Not tested | Positive/negative only (80 ng/mL), n = 8 | Nasopharyngeal and Oropharyngeal swabs | [55] |
Working Only | Steel Mesh + PEDOT-AuNP | Immersion | 30 min | SARS-CoV-2 Ab | Truncated | 20 × 10–2.5 × 10 dilutions | – | Serum | [57] |
Well-plate | Au | 50 L | None | SARS-CoV-2 antibody | RBD protein | 0.1, 1.0, 10 mg/mL standards tested | – | – | [68] |